Citigroup’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3M Sell
670,269
-1,890,491
-74% -$46M 0.01% 799
2025
Q1
$53.2M Buy
2,560,760
+905,515
+55% +$18.8M 0.03% 397
2024
Q4
$39M Sell
1,655,245
-25,400
-2% -$598K 0.02% 424
2024
Q3
$43M Buy
1,680,645
+849,831
+102% +$21.8M 0.02% 419
2024
Q2
$19.5M Sell
830,814
-77,785
-9% -$1.83M 0.01% 647
2024
Q1
$26.1M Buy
908,599
+246,877
+37% +$7.1M 0.02% 546
2023
Q4
$21.7M Buy
661,722
+14,447
+2% +$474K 0.02% 562
2023
Q3
$18M Sell
647,275
-771,729
-54% -$21.5M 0.01% 581
2023
Q2
$48.4M Buy
1,419,004
+16,147
+1% +$550K 0.03% 320
2023
Q1
$42.2M Buy
1,402,857
+1,092,968
+353% +$32.9M 0.03% 341
2022
Q4
$8.75M Sell
309,889
-99,970
-24% -$2.82M 0.01% 857
2022
Q3
$13.5M Buy
409,859
+208,067
+103% +$6.84M 0.01% 706
2022
Q2
$6.35M Sell
201,792
-150,110
-43% -$4.73M ﹤0.01% 1009
2022
Q1
$16.2M Sell
351,902
-15,942
-4% -$732K 0.01% 724
2021
Q4
$22.5M Sell
367,844
-58,093
-14% -$3.56M 0.01% 626
2021
Q3
$31.8M Buy
425,937
+92,448
+28% +$6.91M 0.02% 514
2021
Q2
$30.8M Buy
333,489
+40,489
+14% +$3.75M 0.02% 569
2021
Q1
$26M Buy
293,000
+260,708
+807% +$23.1M 0.02% 600
2020
Q4
$3.01M Buy
32,292
+32,157
+23,820% +$3M ﹤0.01% 1484
2020
Q3
$9K Hold
135
﹤0.01% 4358
2020
Q2
$7K Hold
135
﹤0.01% 4736
2020
Q1
$4K Sell
135
-70
-34% -$2.07K ﹤0.01% 4829
2019
Q4
$7K Hold
205
﹤0.01% 4786
2019
Q3
$6K Hold
205
﹤0.01% 4716
2019
Q2
$7K Hold
205
﹤0.01% 4810
2019
Q1
$7K Sell
205
-341
-62% -$11.6K ﹤0.01% 4814
2018
Q4
$13K Buy
546
+135
+33% +$3.21K ﹤0.01% 4548
2018
Q3
$14K Hold
411
﹤0.01% 4627
2018
Q2
$12K Hold
411
﹤0.01% 4545
2018
Q1
$11K Buy
+411
New +$11K ﹤0.01% 4439